BSEP and MDR3

Autor: Kyoko Otani, Takashi Yamasaki, Maki Kanzawa, Takanori Hirose, Yonson Ku, Kohei Fujikura, Tomoo Itoh, Yoh Zen, Takumi Fukumoto
Rok vydání: 2016
Předmět:
Adult
Male
0301 basic medicine
Pathology
medicine.medical_specialty
ATP Binding Cassette Transporter
Subfamily B

Carcinoma
Hepatocellular

Bile Duct Neoplasm
Pathology and Forensic Medicine
Cholangiocarcinoma
Diagnosis
Differential

03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Biopsy
Biomarkers
Tumor

medicine
Carcinoma
Humans
Esophagus
neoplasms
ATP Binding Cassette Transporter
Subfamily B
Member 11

Aged
Aged
80 and over

medicine.diagnostic_test
business.industry
Liver Neoplasms
Reproducibility of Results
Cell Differentiation
Middle Aged
HCCS
medicine.disease
Immunohistochemistry
digestive system diseases
030104 developmental biology
medicine.anatomical_structure
Bile Duct Neoplasms
030220 oncology & carcinogenesis
Hepatocyte
ATP-Binding Cassette Transporters
Female
Surgery
Anatomy
Differential diagnosis
business
Zdroj: American Journal of Surgical Pathology. 40:689-696
ISSN: 0147-5185
Popis: We herein examined the immunohistochemical expression of 2 hepatocyte-specific transporters (bile salt export pump [BSEP] and multidrug-resistance protein 3 [MDR3]) in hepatocellular carcinomas (HCCs, n=54), intrahepatic cholangiocarcinomas (n=34), combined hepatocellular and cholangiocarcinomas (n=23), and hepatoid carcinomas originated from extrahepatic organs (n=27) to compare their diagnostic values with those of arginase-1 (ARG1) and hepatocyte paraffin-1 (HepPar-1). BSEP was expressed in 91% of HCCs and MDR3 in 83%. Although their sensitivities were slightly lower than those of ARG1 (96%) and HepPar-1 (93%), the 2 transporters appeared to be more specific for HCCs. ARG1 and HepPar-1 were expressed in intrahepatic cholangiocarcinomas (9% and 6%) and hepatoid carcinomas (22% and 44%, respectively), whereas BSEP and MDR3 were entirely negative in these neoplasms, except for 1 case of BSEP-positive hepatoid carcinoma of the esophagus. The highly specific expression of BSEP and MDR3 in hepatocytes was recapitulated in additional examinations of combined hepatocellular and cholangiocarcinomas, in which the expression of the transporters was restricted to morphologically hepatocellular areas. In contrast, ARG1 and HepPar-1 were also variably positive in areas of biliary or indeterminate differentiation. We also applied BSEP and MDR3 immunohistochemistry to 8 biopsy cases of poorly differentiated primary liver cancer, in which the original diagnosis was not conclusive. The diagnosis of HCC was retrospectively suggested in 2 cases expressing both BSEP and MDR3. In conclusion, given the highly specific expression of BSEP and MDR3 in HCCs, immunohistochemistry for these transporters will be useful not only for determining hepatocellular differentiation in primary liver cancers but also for discriminating HCCs from hepatoid carcinomas.
Databáze: OpenAIRE